Point: Combination versus single-agent chemotherapy: The argument for sequential single agents Journal Article


Authors: Conlin, A. K.; Seidman, A. D.
Article Title: Point: Combination versus single-agent chemotherapy: The argument for sequential single agents
Abstract: Metastatic breast cancer is a heterogeneous disease, and treatment decisions depend on several individualized patient and tumor characteristics. Although combination therapy often shows improved response rates in metastatic breast cancer, few studies have shown superiority in overall survival. The choice of combination versus sequential single-agent treatment, therefore, must consider many factors, with no one strategy right for all patients. This article reviews several important clinical trials that address this issue, and argues for single-agent sequential therapy for most patients with metastatic breast cancer. © Journal of the National Comprehensive Cancer Network.
Keywords: cancer chemotherapy; cancer survival; treatment response; survival analysis; survival rate; prednisone; clinical trial; disease course; review; cisplatin; doxorubicin; fluorouracil; cancer growth; monotherapy; treatment planning; antineoplastic agents; capecitabine; gemcitabine; paclitaxel; chemotherapy; methotrexate; outcome assessment; multiple cycle treatment; breast cancer; drug administration schedule; randomized controlled trials as topic; combination chemotherapy; cyclophosphamide; breast neoplasms; vinblastine; docetaxel; systematic review; mitoxantrone; neoplasm metastasis; epirubicin; combination therapy; navelbine; mitomycin; breast metastasis; metastatic breast cancer; meta analysis; drug dose sequence; lonidamine; sequential analysis; sequential therapy; single agent
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 5
Issue: 8
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2007-09-01
Start Page: 668
End Page: 672
Language: English
PUBMED: 17927924
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 2" - "Export Date: 17 November 2011" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Andrew D Seidman
    318 Seidman
  2. Alison Katherine Conlin
    18 Conlin